Levine Mitchell S 4
4 · OncoCyte Corp · Filed Apr 30, 2021
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares, no par value
2021-04-28+20,000→ 66,700 total - Exercise/Conversion
Restricted Stock Units
2021-04-28−20,000→ 0 totalExercise: $0.00→ Common Shares (20,000 underlying) - Tax Payment
Common Shares, no par value
2021-04-28−4,620→ 62,080 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,000 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Restricted Stock Units vested on April 28, 2021.